T2DM still has potential through chronic hyperglycemia, oxidative stress, and advanced glycation end products (AGEs) [39] to disrupt the physiological interaction between PYY and DPP-4; thus, further human studies should address this question. This evidence concerns the gene DPP4 and type 2 diabetes mellitus.